We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 726

'Opioids and Legal EnforcementA Primer'
  • Bradley Arant Boult Cummings LLP
  • USA
  • July 19 2018

The opioid crisis in America is now well known, affecting a staggering number of people directly or indirectly and occupying a regular place in media


Increased Scrutiny of Patient Assistance Programs: Enforcement Overview and Considerations
  • K&L Gates
  • USA
  • March 20 2018

In the midst of ongoing national debates regarding drug pricing and access to innovative therapies, patient assistance programs (“PAPs”) are


Ohio Attorney General Sues Pharmaceutical Companies Over Opioid Marketing - Yet Another Sign of Government Focus on Recovering Financial Cost of Opioid Epidemic
  • Pietragallo Gordon Alfano Bosick & Raspanti LLP
  • USA
  • June 9 2017

Last week, Ohio Attorney General Mike DeWine filed a lawsuit against multiple pharmaceutical companies, including Purdue, Teva, Johnson & Johnson


Fake medicine in Nigeria - When the drugs don’t work
  • Inventa International
  • Nigeria
  • February 21 2017

The presence of counterfeit goods is acknowledged as one of the greatest global threats to creativity. Counterfeiting can be defined as an act of


Drug Companies and Charitable Patient Foundations
  • Volkov Law Group
  • USA
  • August 18 2016

Charitable organizations can easily become enmeshed in Justice Department enforcement issues. We have seen charities used in FCPA cases as a means to


Pharmacist Pleads Guilty to Healthcare Fraud and Filing False Tax Returns
  • FisherBroyles LLP
  • USA
  • June 1 2016

New York pharmacist, Andrew Barrett pled guilty last week to falsely billing Medicare and Medicaid more than $2.7 million for HIV medication refills


Drug and Medical Device Corruption Risks in China
  • Volkov Law Group
  • USA, China
  • March 7 2016

Medical device and pharmaceutical companies know the risks of conducting business in China. Company after company has had to settle FCPA enforcement


Specialty pharmacy takeaways - OIG free drug program Advisory Opinion 15-11
  • Bass, Berry & Sims PLC
  • USA
  • August 18 2015

On August 13, 2015 the Office of Inspector General (OIG) issued a favorable Advisory Opinion (Opinion) regarding a free drug program sponsored by


Compounded drugs marketed to TRICARE beneficiaries undergoing close examination by federal investigators
  • Roetzel & Andress
  • USA
  • May 11 2015

Ongoing investigations by both the Department of Defense (DOD) and a major U.S. media organization allege that suspicious marketing and prescribing


Criminal RICO indictment for pharma execs in alleged second-degree murder for improper drug production leading to fungal meningitis deaths
  • Manatt Phelps & Phillips LLP
  • USA
  • March 19 2015

Charging corporate executives under criminal RICO in this situation where deaths occurred as a result of alleged improper drug compounding and